Concern Over Biosimilar-To-Biosimilar Switch Could Impact Approval, US FDA Official Says

 
• By Derrick Gingery
biosimilar switching concept
An upcoming FDA workshop could help streamline biosimilar development. • Source: Shutterstock

More from Biosimilars

More from Biosimilars & Generics